Effectiveness of Integrated Palliative and Oncology Care for Patients With Acute Myeloid Leukemia
Author(s) -
Areej ElJawahri,
Thomas W. LeBlanc,
Alison R. Kavanaugh,
Jason A. Webb,
Vicki A. Jackson,
Toby C. Campbell,
Nina O’Connor,
Selina M. Luger,
Ellin Gafford,
Jillian Gustin,
Bhavana Bhatnagar,
Alison R. Walker,
Amir T. Fathi,
Andrew M. Brunner,
Gabriela S. Hobbs,
Showly Nicholson,
D. Davis,
Hilena Addis,
Dagny Vaughn,
Nora Horick,
Joseph A. Greer,
Jennifer S. Temel
Publication year - 2020
Publication title -
jama oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 8.846
H-Index - 99
eISSN - 2374-2445
pISSN - 2374-2437
DOI - 10.1001/jamaoncol.2020.6343
Subject(s) - medicine , hospital anxiety and depression scale , palliative care , quality of life (healthcare) , myeloid leukemia , anxiety , depression (economics) , randomized controlled trial , population , specialty , oncology , psychiatry , nursing , environmental health , economics , macroeconomics
Patients with acute myeloid leukemia (AML) receiving intensive chemotherapy experience substantial decline in their quality of life (QOL) and mood during their hospitalization for induction chemotherapy and often receive aggressive care at the end of life (EOL). However, the role of specialty palliative care for improving the QOL and care for this population is currently unknown.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom